These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 18815926)
1. Bladder cancer subtypes defined by genomic alterations. Knowles MA Scand J Urol Nephrol Suppl; 2008 Sep; (218):116-30. PubMed ID: 18815926 [TBL] [Abstract][Full Text] [Related]
2. Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium. Goebell PJ; Knowles MA Urol Oncol; 2010; 28(4):409-28. PubMed ID: 20610279 [TBL] [Abstract][Full Text] [Related]
3. Molecular alterations associated with bladder cancer initiation and progression. Cordon-Cardo C Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930 [TBL] [Abstract][Full Text] [Related]
4. Genetic epidemiology of bladder cancer: scaling up in the identification of low-penetrance genetic markers of bladder cancer risk and progression. Malats N Scand J Urol Nephrol Suppl; 2008 Sep; (218):131-40. PubMed ID: 18815927 [TBL] [Abstract][Full Text] [Related]
6. [Study of bladder cancer gene and relevant molecular biology should be strengthened]. Li CL; Han SJ Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):793-4. PubMed ID: 17565855 [No Abstract] [Full Text] [Related]
7. Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging. Sugano K; Kakizoe T Nat Clin Pract Urol; 2006 Dec; 3(12):642-52. PubMed ID: 17149381 [TBL] [Abstract][Full Text] [Related]
8. Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? Knowles MA Carcinogenesis; 2006 Mar; 27(3):361-73. PubMed ID: 16352616 [TBL] [Abstract][Full Text] [Related]
9. Molecular markers for detection, surveillance and prognostication of bladder cancer. Vrooman OP; Witjes JA Int J Urol; 2009 Mar; 16(3):234-43. PubMed ID: 19298346 [TBL] [Abstract][Full Text] [Related]
10. Molecular genetics of bladder cancer: pathways of development and progression. Knowles MA Cancer Surv; 1998; 31():49-76. PubMed ID: 15281317 [No Abstract] [Full Text] [Related]
14. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder. Vázquez-Lavista LG; Lima G; Gabilondo F; Llorente L Urology; 2009 Aug; 74(2):414-8. PubMed ID: 19646633 [TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer. Jarmalaite S; Jankevicius F; Kurgonaite K; Suziedelis K; Mutanen P; Husgafvel-Pursiainen K Oncology; 2008; 75(3-4):145-51. PubMed ID: 18824877 [TBL] [Abstract][Full Text] [Related]
16. How to combine the molecular profile with the clinicopathological profile of urothelial neoplastic lesions. van der Kwast TH Scand J Urol Nephrol Suppl; 2008 Sep; (218):175-84. PubMed ID: 18815932 [TBL] [Abstract][Full Text] [Related]
17. Activation of RAS family genes in urothelial carcinoma. Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097 [TBL] [Abstract][Full Text] [Related]